Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Smoking, Tobacco: full-pipeline trial registry
5 of 19 indexed Smoking, Tobacco trials are currently recruiting.
Corpus placement: #902 of 28,707 conditions by registered trial count.
19 US clinical trials · 5 currently recruiting · #902 of 28,707 conditions by registered trial count
Smoking, Tobacco: 19 US clinical trials tracked, 5 recruiting.
Smoking, Tobacco is the subject of 19 registered US clinical trials on ClinicalTrials.gov, 5 of them currently open to new participants. 2 are in Phase 3-4 (later-stage) and 2 in Phase 1-2 (earlier-stage). The most active sponsor is Dana-Farber Cancer Institute, running 2 of these trials.
Enrollment posture brief
Registry condition smoking-tobacco
OPEN 5 | RECR 26% | LATE 2 | EARLY 2 | RANK #902 | SPON 2
Volume-matched condition peers
Nearest open-share peer: Concussion, Mild (26% recruiting · 19 trials)
Smoking, Tobacco lists 5 open slots (26% of 19 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Smoking, Tobacco on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Smoking, Tobacco is recruiting below its size-band peers.
5 of 19 indexed trials (26.3%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
Sponsorship of Smoking, Tobacco trials is spread across many organizations.
Dana-Farber Cancer Institute accounts for 2 of 19 trials (10.5%). 16 distinct sponsors appear on at least one study for this condition label.
-
Typical Smoking, Tobacco enrolment sits around 100 participants.
Median target enrolment is 100 among the 19 trials that report a genuine target (sentinel values excluded). 9 of those (47.4%) plan for fewer than 100 participants.
-
Smoking, Tobacco research is mostly interventional.
18 interventional and 1 observational studies make up this index (94.7% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
19 total, page 1 of 1
The Efficacy of Conventional Screening Versus mHealth Screening in Early Detection of Oral Potentially Malignant Disorders and Oral Cancer Amongst the Rural Population of Varanasi: A Prospective and Blinded Study
Memorial Sloan Kettering Cancer Center
NCT06535867
Leveraging Community Pharmacists to Optimize Smoking Cessation Services for Rural Smokers in Appalachia
University of Virginia
NCT05660525
V+PSF-M for Tobacco Cessation in HIV Care in India
University of Colorado, Denver
NCT05786547
ACT Lung Health Intervention: Phase Two
Dana-Farber Cancer Institute
NCT06945120
A Study Evaluating the Use of an Indoor Air Quality Monitor to Promote a Smoke-free Home
Memorial Sloan Kettering Cancer Center
NCT06693700
Digitally Enhanced Smoking Cessation for High Risk Smokers
Dana-Farber Cancer Institute
NCT04691297
Nicotinic Hepatic Metabolism on Neuroreceptor Substrates of Nicotine Addiction
University of Pennsylvania
NCT03442413
The Whole Day First Grade Program
American Institutes for Research
NCT00257088
Helping Poor Smokers Quit
Washington University School of Medicine
NCT03194958
A Facebook Intervention for Young Sexual and Gender Minority Smokers
University of California, San Francisco
NCT03259360
A Guided Imagery Tobacco Cessation Intervention Delivered by a Quit Line and Website
University of Arizona
NCT02968381
Applying Novel Technologies and Methods to Inform the Ontology of Self-Regulation: Binge Eating and Smoking
Stanford University
NCT03353649
Tobacco Cessation Intervention
Barbara Ann Karmanos Cancer Institute
NCT03657511
Hollings Cancer Center Varenicline Sampling Study
Medical University of South Carolina
NCT03742154
Personalized Feedback for Smokers With Elevated Anxiety Sensitivity
University of Houston
NCT03382093
Contingency Management for Smoking Cessation
University of California, San Francisco
NCT04982952
Connecting Alaska Native People to Quit Smoking
Mayo Clinic
NCT03645941
BRP1602: Evaluation of Technical and Logistical Feasibility to Measure Lung Permeability
RAI Services Company
NCT06105424
Tobacco Cessation in Public Housing
Johns Hopkins University
NCT04889638
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 2 |
| Phase 3 | 1 |
| Phase 4 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Smoking, Tobacco records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Smoking, Tobacco trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Smoking, Tobacco page
19 registered trials, 5 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 5 Smoking, Tobacco trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Dana-Farber Cancer Institute sponsors the most Smoking, Tobacco trials on record, review their full trial history before evaluating a specific study. See Dana-Farber Cancer Institute's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Smoking, Tobacco condition card totals 19 registered trials; most-linked intervention Lung Permeability Assessment; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.